MASI Overview

Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.

Wall Street analysts forecast MASI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MASI is188.40 USD with a low forecast of 162.00 USD and a high forecast of 210.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Masimo Corp revenue for the last quarter amounts to 403.60M USD, increased 8.49

Masimo Corp. EPS for the last quarter amounts to 1.10 USD, decreased -134.81

Masimo Corp (MASI) has 2200 emplpoyees as of June 21 2026.

Today MASI has the market capitalization of 6.99B USD.